Multiple binding sites for melatonin on Kv1.3.

Area of Science:

• Immunology
• Neuroendocrinology
• Channel Physiology

Background:

• Melatonin, a hormone from the pineal gland, influences various physiological processes.
• Kv1.3 channels are crucial voltage-gated potassium channels in human T-lymphocytes, regulating immune cell function.
• Understanding melatonin's interaction with ion channels is key to its immunomodulatory roles.

Purpose of the Study:

• To investigate the interaction between melatonin and Kv1.3 channels in human T-lymphocytes.
• To characterize the blocking kinetics and binding stoichiometry of melatonin on Kv1.3 channels.
• To elucidate the location of the melatonin binding site and its allosteric modulation.

Main Methods:

• Electrophysiological recordings (e.g., patch-clamp) to measure Kv1.3 channel currents.
• Dose-response analysis to determine half-blocking concentration and binding affinity.
• Co-application experiments with known channel blockers (charybdotoxin, tetraethylammonium) to probe binding site location.

Main Results:

• Melatonin rapidly and reversibly blocked Kv1.3 channels from the extracellular side.
• The block was non-state and non-voltage-dependent, increasing channel inactivation.
• A model with one of four binding sites sufficient for block best fit data, with a dissociation constant of 8.11 mM.
• Melatonin and charybdotoxin bind simultaneously, indicating the binding site is outside the pore.
• Tetraethylammonium binding allosterically decreased melatonin affinity, and vice versa.

Conclusions:

• Melatonin acts as a blocker of Kv1.3 channels in T-lymphocytes.
• The interaction involves specific binding sites that are allosterically coupled.
• These findings provide insights into the molecular mechanisms of melatonin's immunomodulatory effects.